As Appalachian Power continues to look into bringing a small modular reactor (SMR) to the area, ABC13 spoke with the group that has the final say.

The US FDA has granted priority review to AstraZeneca's sBLA for Imfinzi (durvalumab) for muscle-invasive bladder cancer (MIBC) treatment.

If approved, durvalumab will be the first and only perioperative immunotherapy regimen available for the treatment of ...

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...

The Priority Current has spent years as the flagship electric bike produced by Manhattan-based Priority Bicycles. Now the ...

Investors will increasingly prioritize founders and teams who can lead with vision, scale effectively, and build resilient, ...

Ministers have been told to stop spending that does not contribute to the government's priorities, as Chancellor Rachel ...

Various ‘push-and-pull’ mechanisms have been tried to attract pharmaceutical companies into medical innovation for public ...

The Food and Drug Administration (FDA) has granted Priority Review to durvalumab for the treatment of adults with muscle-invasive bladder cancer (MIBC). The coprimary endpoints were pathological ...

December 06, 2024--(BUSINESS WIRE)--AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI ® (durvalumab) has been accepted and granted Priority Review in the US for the ...

Going out to eat? See which Marion County restaurants were rated best by inspectors, and which failed the test.